Safety and efficacy of a feed additive consisting of the bacteriophages PCM F/00069, PCM F/00070, PCM F/00071 and PCM F/00097 (Bafasal®) for all poultry (Proteon Pharmaceuticals S.A.)

Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of a product consisting of four bacteriophages infecting <i>Salmonella enterica</i> ser. Gallinarum B/00111, intended for be as a zootechnical additive (functional group: other zootechnical additives) for all poultry species. Bafasal® is proposed for use in water for drinking and liquid complementary feed to guarantee a minimum daily dose of 2 × 10<sup>6</sup> PFU/bird, to reduce the <i>Salmonella</i> spp. contamination of poultry carcasses and load in the environment, and to improve the zootechnical performance of the treated animals. In previous opinions, the FEEDAP Panel concluded that Bafasal® is safe for the target species, consumers and the environment and is not a skin or eye irritant but should be considered a respiratory sensitiser. No conclusion could be drawn on its dermal sensitisation potential. The additive showed the potential to decrease the counts of two Salmonella Enteritidis strains in boots swabs and caecal digesta of chickens for fattening. However, the Panel was not in the position to conclude on the capacity of Bafasal® to improve the zootechnical performance of poultry, to reduce the contamination of other <i>Salmonella enterica</i> strains, serovars or other <i>Salmonella</i> spp. in chickens, or to reduce the <i>Salmonella</i> spp. contamination of poultry other than chickens. In the current application, the claim on zootechnical performance has been withdrawn. Bafasal® is not a skin or eye irritant but should be considered a potential skin and respiratory sensitiser and inhalation and dermal exposure is considered a risk. Based on the new data provided, the Panel concluded that Bafasal® has the potential to reduce the environmental contamination with <i>S.</i> Enteritidis when used in feed and water for all poultry species. No conclusions could be drawn on the effects of the additive on other <i>Salmonella</i> serotypes.

Authors

Publication Details

Journal
EFSA Journal
Published
2024-12-01
DOI
https://doi.org/10.2903/j.efsa.2024.9132
Citations
6
Primary Topic
Agricultural safety and regulations
Type
article
Field-Weighted Citation Impact
2.09
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and efficacy of a feed additive consisting of the bacteriophages PCM F/00069, PCM F/00070, PCM F/00071 and PCM F/00097 (Bafasal®) for all poultry (Proteon Pharmaceuticals S.A.)

Vasileios Bampidis, Ilen Röhe, Alena Pechová, Eleftherios Bonos et al.
6 citations
EFSA Journal
Agricultural safety and regulations
2.09
article

Safety and efficacy of a feed additive consisting of the bacteriophages PCM F/00069, PCM F/00070, PCM F/00071 and PCM F/00097 (Bafasal®) for all poultry (Proteon Pharmaceuticals S.A.)

Vasileios Bampidis, Ilen Röhe, Alena Pechová, Eleftherios Bonos, Henrik Christensen, Roberto Edoardo Villa, Katerina Theodoridou, Marta López‐Alonso, Francesca Marcon, Ronette Gehring, Jordi Ortuño, Carlo Nebbia, Rosella Brozzi, Miguel Prieto Maradona, Mojca Durjava, Pier Sandro Cocconcelli, Maryline Kouba, Boet Glandorf, Giovanna Azimonti, Birgit Dusemund, Lieve Herman, Montserrat Anguita, Jaume Galobart, Matteo L. Innocenti
article en
6 citations

Abstract

Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of a product consisting of four bacteriophages infecting <i>Salmonella enterica</i> ser. Gallinarum B/00111, intended for be as a zootechnical additive (functional group: other zootechnical additives) for all poultry species. Bafasal® is proposed for use in water for drinking and liquid complementary feed to guarantee a minimum daily dose of 2 × 10<sup>6</sup> PFU/bird, to reduce the <i>Salmonella</i> spp. contamination of poultry carcasses and load in the environment, and to improve the zootechnical performance of the treated animals. In previous opinions, the FEEDAP Panel concluded that Bafasal® is safe for the target species, consumers and the environment and is not a skin or eye irritant but should be considered a respiratory sensitiser. No conclusion could be drawn on its dermal sensitisation potential. The additive showed the potential to decrease the counts of two Salmonella Enteritidis strains in boots swabs and caecal digesta of chickens for fattening. However, the Panel was not in the position to conclude on the capacity of Bafasal® to improve the zootechnical performance of poultry, to reduce the contamination of other <i>Salmonella enterica</i> strains, serovars or other <i>Salmonella</i> spp. in chickens, or to reduce the <i>Salmonella</i> spp. contamination of poultry other than chickens. In the current application, the claim on zootechnical performance has been withdrawn. Bafasal® is not a skin or eye irritant but should be considered a potential skin and respiratory sensitiser and inhalation and dermal exposure is considered a risk. Based on the new data provided, the Panel concluded that Bafasal® has the potential to reduce the environmental contamination with <i>S.</i> Enteritidis when used in feed and water for all poultry species. No conclusions could be drawn on the effects of the additive on other <i>Salmonella</i> serotypes.

EFSA JournalVol. 22(12)
Clean water and sanitation
Openalex Percentile: Top 14%
Agricultural safety and regulations
2.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.